Literature DB >> 17062879

RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.

Massimo Santoro1, Rosa Marina Melillo, Alfredo Fusco.   

Abstract

Papillary thyroid carcinoma (PTC) is frequently associated with RET gene rearrangements that generate the so-called RET/PTC oncogenes. In this review, we examine the data about the mechanisms of thyroid cell transformation, activation of downstream signal transduction pathways and modulation of gene expression induced by RET/PTC. These findings have advanced our understanding of the processes underlying PTC formation and provide the basis for novel therapeutic approaches to this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062879     DOI: 10.1530/eje.1.02289

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  62 in total

Review 1.  The discovery and development of sorafenib for the treatment of thyroid cancer.

Authors:  Peter T White; Mark S Cohen
Journal:  Expert Opin Drug Discov       Date:  2015-02-08       Impact factor: 6.098

Review 2.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 3.  Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

Review 4.  Values of molecular markers in the differential diagnosis of thyroid abnormalities.

Authors:  T M P B Tennakoon; M Rushdhi; A D C U Ranasinghe; R S Dassanayake
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-22       Impact factor: 4.553

5.  Long-range transcriptome sequencing reveals cancer cell growth regulatory chimeric mRNA.

Authors:  Roberto Plebani; Gavin R Oliver; Marco Trerotola; Emanuela Guerra; Pamela Cantanelli; Luana Apicella; Andrew Emerson; Alessandro Albiero; Paul D Harkin; Richard D Kennedy; Saverio Alberti
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

Review 6.  Molecular pathogenesis and mechanisms of thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Nat Rev Cancer       Date:  2013-03       Impact factor: 60.716

7.  Drosophila Cancer Models Identify Functional Differences between Ret Fusions.

Authors:  Sarah Levinson; Ross L Cagan
Journal:  Cell Rep       Date:  2016-09-13       Impact factor: 9.423

Review 8.  Recent advances in molecular biology of thyroid cancer and their clinical implications.

Authors:  Mingzhao Xing
Journal:  Otolaryngol Clin North Am       Date:  2008-12       Impact factor: 3.346

9.  Genomic copy number analysis of Chernobyl papillary thyroid carcinoma in the Ukrainian-American Cohort.

Authors:  Martin Selmansberger; Herbert Braselmann; Julia Hess; Tetiana Bogdanova; Michael Abend; Mykola Tronko; Alina Brenner; Horst Zitzelsberger; Kristian Unger
Journal:  Carcinogenesis       Date:  2015-08-29       Impact factor: 4.944

10.  DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells.

Authors:  M Gandhi; L W Dillon; S Pramanik; Y E Nikiforov; Y-H Wang
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.